Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Major

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Dalton Transactions (Cambridge, England : 2003)|July 9, 2024
Correction: A chelated borinium cationChristopher Major, Alan Lough, Douglas W Stephan
Dalton Transactions (Cambridge, England : 2003)|June 10, 2024
A chelated borinium cationChristopher Major, Alan Lough, Douglas W Stephan
Molecular Pharmacology|February 24, 2004
SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7Stacey DaCosta Byfield, Christopher Major, Nicholas J Laping, et al.
The Journal of Pathology. Clinical Research|April 19, 2020
Identifying fibroblast growth factor receptor genetic alterations using RNA-based assays in patients with metastatic or locally advanced, surgically unresectable, urothelial carcinoma who may benefit from erdafitinib treatmentSongbai Wang, Mike Burgess, Christopher Major, et al.
Chiropractic & Manual Therapies|January 8, 2025
The association between individual radiographic findings and improvement after chiropractic spinal manipulation and home exercise among older adults with back-related disability: a secondary analysisMichele J Maiers, Andrea K Albertson, Christopher Major, et al.
Journal of Chromatography. A|November 26, 2025
Integrating the affinity and anion-exchange purification of AAV8: how the selective enrichment of full capsids at the affinity capture step enhances the downstream processing of gene therapiesShriarjun Shastry, Arianna Minzoni, Morgan R Hurst, et al.
The American Journal of Pathology|March 14, 2002
Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiationKathleen C Flanders, Catherine D Sullivan, Makiko Fujii, et al.
British Journal of Haematology|May 4, 2021
Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B-cell lymphoma in the phase III clinical trial of R-CHOP ± ibrutinibSriram Balasubramanian, Songbai Wang, Christopher Major, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Dalton Transactions (Cambridge, England : 2003)|July 9, 2024
Correction: A chelated borinium cationChristopher Major, Alan Lough, Douglas W Stephan
Dalton Transactions (Cambridge, England : 2003)|June 10, 2024
A chelated borinium cationChristopher Major, Alan Lough, Douglas W Stephan
Molecular Pharmacology|February 24, 2004
SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7Stacey DaCosta Byfield, Christopher Major, Nicholas J Laping, et al.
The Journal of Pathology. Clinical Research|April 19, 2020
Identifying fibroblast growth factor receptor genetic alterations using RNA-based assays in patients with metastatic or locally advanced, surgically unresectable, urothelial carcinoma who may benefit from erdafitinib treatmentSongbai Wang, Mike Burgess, Christopher Major, et al.
Chiropractic & Manual Therapies|January 8, 2025
The association between individual radiographic findings and improvement after chiropractic spinal manipulation and home exercise among older adults with back-related disability: a secondary analysisMichele J Maiers, Andrea K Albertson, Christopher Major, et al.
Journal of Chromatography. A|November 26, 2025
Integrating the affinity and anion-exchange purification of AAV8: how the selective enrichment of full capsids at the affinity capture step enhances the downstream processing of gene therapiesShriarjun Shastry, Arianna Minzoni, Morgan R Hurst, et al.
The American Journal of Pathology|March 14, 2002
Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiationKathleen C Flanders, Catherine D Sullivan, Makiko Fujii, et al.
British Journal of Haematology|May 4, 2021
Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B-cell lymphoma in the phase III clinical trial of R-CHOP ± ibrutinibSriram Balasubramanian, Songbai Wang, Christopher Major, et al.
Pageof 1